Immunoprecise Stock Market Value

IPA -  USA Stock  

USD 4.14  0.15  3.50%

Immunoprecise Antibodies' market value is the price at which a share of Immunoprecise Antibodies stock trades on a public exchange. It measures the collective expectations of Immunoprecise Antibodies investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Immunoprecise Antibodies and determine expected loss or profit from investing in Immunoprecise Antibodies over a given investment horizon. Please see Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Correlation, Immunoprecise Antibodies Valuation, Immunoprecise Antibodies Volatility, as well as analyze Immunoprecise Antibodies Alpha and Beta and Immunoprecise Antibodies Performance.
Symbol
Backtest


Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
101.5 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Immunoprecise Antibodies 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunoprecise Antibodies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunoprecise Antibodies.
0.00
07/04/2020
No Change 0.00  0.0 
In 1 year 11 months and 22 days
06/24/2022
0.00
If you would invest  0.00  in Immunoprecise Antibodies on July 4, 2020 and sell it all today you would earn a total of 0.00 from holding Immunoprecise Antibodies or generate 0.0% return on investment in Immunoprecise Antibodies over 720 days. Immunoprecise Antibodies is related to or competes with Moderna. ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in th...More

Immunoprecise Antibodies Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunoprecise Antibodies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunoprecise Antibodies upside and downside potential and time the market with a certain degree of confidence.

Immunoprecise Antibodies Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunoprecise Antibodies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunoprecise Antibodies' standard deviation. In reality, there are many statistical measures that can use Immunoprecise Antibodies historical prices to predict the future Immunoprecise Antibodies' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Immunoprecise Antibodies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Immunoprecise Antibodies in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.224.369.14
Details
Intrinsic
Valuation
LowReal ValueHigh
1.536.3111.09
Details
Naive
Forecast
LowNext ValueHigh
0.083.888.66
Details
1 Analysts
Consensus
LowTarget PriceHigh
12.0012.0012.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immunoprecise Antibodies. Your research has to be compared to or analyzed against Immunoprecise Antibodies' peers to derive any actionable benefits. When done correctly, Immunoprecise Antibodies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Immunoprecise Antibodies.

Immunoprecise Antibodies Backtested Returns

Immunoprecise Antibodies holds Efficiency (Sharpe) Ratio of -0.15, which attests that the entity had -0.15% of return per unit of risk over the last 2 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Immunoprecise Antibodies exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Immunoprecise Antibodies market risk adjusted performance of (0.51), and Risk Adjusted Performance of (0.21) to validate the risk estimate we provide.
The company retains a Market Volatility (i.e., Beta) of 1.2233, which attests to a somewhat significant risk relative to the market. Let's try to break down what Immunoprecise's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immunoprecise Antibodies will likely underperform. Even though it is essential to pay attention to Immunoprecise Antibodies current price history, it is always good to be careful when utilizing equity current price movements. Our philosophy towards determining any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Immunoprecise Antibodies exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Immunoprecise Antibodies has an expected return of -0.71%. Please be advised to check out Immunoprecise Antibodies downside variance, daily balance of power, and the relationship between the maximum drawdown and skewness to decide if Immunoprecise Antibodies performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.48  

Modest reverse predictability

Immunoprecise Antibodies has modest reverse predictability. Overlapping area represents the amount of predictability between Immunoprecise Antibodies time series from 4th of July 2020 to 29th of June 2021 and 29th of June 2021 to 24th of June 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunoprecise Antibodies price movement. The serial correlation of -0.48 indicates that about 48.0% of current Immunoprecise Antibodies price fluctuation can be explain by its past prices.
Correlation Coefficient-0.48
Spearman Rank Test-0.42
Residual Average0.0
Price Variance1.05

Immunoprecise Antibodies lagged returns against current returns

Autocorrelation, which is Immunoprecise Antibodies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immunoprecise Antibodies' stock expected returns. We can calculate the autocorrelation of Immunoprecise Antibodies returns to help us make a trade decision. For example, suppose you find that Immunoprecise Antibodies stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 
Share
      Timeline 

Immunoprecise Antibodies regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immunoprecise Antibodies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immunoprecise Antibodies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immunoprecise Antibodies stock over time.
 Current vs Lagged Prices 
Share
      Timeline 

Immunoprecise Antibodies Lagged Returns

When evaluating Immunoprecise Antibodies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immunoprecise Antibodies stock have on its future price. Immunoprecise Antibodies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immunoprecise Antibodies autocorrelation shows the relationship between Immunoprecise Antibodies stock current value and its past values and can show if there is a momentum factor associated with investing in Immunoprecise Antibodies.
 Regressed Prices 
Share
      Timeline 

Immunoprecise Antibodies Investors Sentiment

The influence of Immunoprecise Antibodies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunoprecise. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Immunoprecise Antibodies Implied Volatility

    
  109.25  
Immunoprecise Antibodies' implied volatility exposes the market's sentiment of Immunoprecise Antibodies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Immunoprecise Antibodies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Immunoprecise Antibodies stock will not fluctuate a lot when Immunoprecise Antibodies' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunoprecise Antibodies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunoprecise Antibodies' short interest history, or implied volatility extrapolated from Immunoprecise Antibodies options trading.

Current Sentiment - IPA

Immunoprecise Antibodies Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Immunoprecise Antibodies. What is your judgment towards investing in Immunoprecise Antibodies? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Correlation, Immunoprecise Antibodies Valuation, Immunoprecise Antibodies Volatility, as well as analyze Immunoprecise Antibodies Alpha and Beta and Immunoprecise Antibodies Performance. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Immunoprecise Antibodies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunoprecise Antibodies technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunoprecise Antibodies trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...